vs
Side-by-side financial comparison of Arteris, Inc. (AIP) and GYRE THERAPEUTICS, INC. (GYRE). Click either name above to swap in a different company.
GYRE THERAPEUTICS, INC. is the larger business by last-quarter revenue ($37.2M vs $20.1M, roughly 1.8× Arteris, Inc.). GYRE THERAPEUTICS, INC. runs the higher net margin — -3.7% vs -42.2%, a 38.6% gap on every dollar of revenue. On growth, GYRE THERAPEUTICS, INC. posted the faster year-over-year revenue change (33.4% vs 30.0%). Arteris, Inc. produced more free cash flow last quarter ($3.0M vs $-5.8M). Over the past eight quarters, Arteris, Inc.'s revenue compounded faster (24.7% CAGR vs 17.0%).
Arteris, Inc. is a multinational technology company headquartered in Campbell, California. It develops the network-on-chip (NoC) IP and system-on-chip (SoC) integration automation software that is used to create semiconductor chip and chiplet designs for a variety of devices, particularly in automotive electronics, artificial intelligence, machine learning, enterprise computing, communications, consumer, industrial, and aerospace & defense markets. The company specializes in the development a...
GYRE Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing novel targeted therapies for hard-to-treat hematologic malignancies and solid tumors. It focuses on precision oncology to address unmet patient needs, with operations primarily based in North America.
AIP vs GYRE — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $20.1M | $37.2M |
| Net Profit | $-8.5M | $-1.4M |
| Gross Margin | 90.8% | 95.3% |
| Operating Margin | -42.0% | 0.3% |
| Net Margin | -42.2% | -3.7% |
| Revenue YoY | 30.0% | 33.4% |
| Net Profit YoY | -3.7% | -340.1% |
| EPS (diluted) | $-0.19 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $20.1M | $37.2M | ||
| Q3 25 | $17.4M | $30.6M | ||
| Q2 25 | $16.5M | $26.8M | ||
| Q1 25 | $16.5M | $22.1M | ||
| Q4 24 | $15.5M | $27.9M | ||
| Q3 24 | $14.7M | $25.5M | ||
| Q2 24 | $14.6M | $25.2M | ||
| Q1 24 | $12.9M | $27.2M |
| Q4 25 | $-8.5M | $-1.4M | ||
| Q3 25 | $-9.0M | $5.9M | ||
| Q2 25 | $-9.1M | $1.6M | ||
| Q1 25 | $-8.1M | $3.7M | ||
| Q4 24 | $-8.2M | $569.0K | ||
| Q3 24 | $-7.7M | $2.9M | ||
| Q2 24 | $-8.3M | $4.5M | ||
| Q1 24 | $-9.4M | $9.9M |
| Q4 25 | 90.8% | 95.3% | ||
| Q3 25 | 89.9% | 94.7% | ||
| Q2 25 | 89.4% | 95.7% | ||
| Q1 25 | 90.8% | 95.9% | ||
| Q4 24 | 89.8% | 95.8% | ||
| Q3 24 | 90.1% | 96.2% | ||
| Q2 24 | 90.0% | 96.9% | ||
| Q1 24 | 88.7% | 96.4% |
| Q4 25 | -42.0% | 0.3% | ||
| Q3 25 | -50.1% | 22.7% | ||
| Q2 25 | -50.0% | 8.1% | ||
| Q1 25 | -46.6% | 10.3% | ||
| Q4 24 | -45.9% | 2.4% | ||
| Q3 24 | -53.8% | 16.6% | ||
| Q2 24 | -51.1% | 12.7% | ||
| Q1 24 | -70.5% | 29.7% |
| Q4 25 | -42.2% | -3.7% | ||
| Q3 25 | -51.6% | 19.4% | ||
| Q2 25 | -55.3% | 5.9% | ||
| Q1 25 | -49.1% | 16.9% | ||
| Q4 24 | -53.0% | 2.0% | ||
| Q3 24 | -52.2% | 11.2% | ||
| Q2 24 | -57.2% | 18.0% | ||
| Q1 24 | -72.6% | 36.6% |
| Q4 25 | $-0.19 | $-0.01 | ||
| Q3 25 | $-0.21 | $0.03 | ||
| Q2 25 | $-0.22 | $0.00 | ||
| Q1 25 | $-0.20 | $0.00 | ||
| Q4 24 | $-0.19 | $0.00 | ||
| Q3 24 | $-0.20 | $0.01 | ||
| Q2 24 | $-0.22 | $0.01 | ||
| Q1 24 | $-0.25 | $0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $33.9M | $52.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-14.6M | $106.0M |
| Total Assets | $115.0M | $166.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $33.9M | $52.4M | ||
| Q3 25 | $39.0M | $60.0M | ||
| Q2 25 | $38.0M | $54.4M | ||
| Q1 25 | $42.3M | $29.9M | ||
| Q4 24 | $43.8M | $26.7M | ||
| Q3 24 | $48.7M | $25.1M | ||
| Q2 24 | $45.8M | $25.1M | ||
| Q1 24 | $44.8M | $37.4M |
| Q4 25 | $-14.6M | $106.0M | ||
| Q3 25 | $-11.4M | $101.9M | ||
| Q2 25 | $-7.5M | $92.0M | ||
| Q1 25 | $-4.8M | $68.1M | ||
| Q4 24 | $-1.2M | $63.3M | ||
| Q3 24 | $2.2M | $63.2M | ||
| Q2 24 | $5.3M | $60.4M | ||
| Q1 24 | $9.5M | $56.6M |
| Q4 25 | $115.0M | $166.1M | ||
| Q3 25 | $107.7M | $159.4M | ||
| Q2 25 | $106.9M | $152.6M | ||
| Q1 25 | $98.3M | $129.8M | ||
| Q4 24 | $106.1M | $125.4M | ||
| Q3 24 | $97.7M | $125.2M | ||
| Q2 24 | $96.4M | $120.9M | ||
| Q1 24 | $101.4M | $122.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $3.2M | $-5.6M |
| Free Cash FlowOCF − Capex | $3.0M | $-5.8M |
| FCF MarginFCF / Revenue | 15.1% | -15.5% |
| Capex IntensityCapex / Revenue | 0.7% | 0.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $5.3M | $-180.0K |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.2M | $-5.6M | ||
| Q3 25 | $3.2M | $4.7M | ||
| Q2 25 | $-2.5M | $2.1M | ||
| Q1 25 | $2.9M | $-129.0K | ||
| Q4 24 | $-2.6M | $-2.8M | ||
| Q3 24 | $1.1M | $1.7M | ||
| Q2 24 | $311.0K | $-5.5M | ||
| Q1 24 | $477.0K | $2.9M |
| Q4 25 | $3.0M | $-5.8M | ||
| Q3 25 | $2.5M | $4.0M | ||
| Q2 25 | $-2.8M | $1.8M | ||
| Q1 25 | $2.7M | $-251.0K | ||
| Q4 24 | $-2.7M | $-2.8M | ||
| Q3 24 | $1.1M | $1.0M | ||
| Q2 24 | $264.0K | $-6.9M | ||
| Q1 24 | $281.0K | $2.7M |
| Q4 25 | 15.1% | -15.5% | ||
| Q3 25 | 14.2% | 13.1% | ||
| Q2 25 | -17.2% | 6.8% | ||
| Q1 25 | 16.2% | -1.1% | ||
| Q4 24 | -17.3% | -10.1% | ||
| Q3 24 | 7.4% | 4.1% | ||
| Q2 24 | 1.8% | -27.5% | ||
| Q1 24 | 2.2% | 9.8% |
| Q4 25 | 0.7% | 0.4% | ||
| Q3 25 | 4.1% | 2.2% | ||
| Q2 25 | 2.2% | 1.0% | ||
| Q1 25 | 1.1% | 0.6% | ||
| Q4 24 | 0.3% | 0.2% | ||
| Q3 24 | 0.2% | 2.7% | ||
| Q2 24 | 0.3% | 5.8% | ||
| Q1 24 | 1.5% | 0.9% |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.79× | ||
| Q2 25 | — | 1.32× | ||
| Q1 25 | — | -0.03× | ||
| Q4 24 | — | -4.85× | ||
| Q3 24 | — | 0.60× | ||
| Q2 24 | — | -1.21× | ||
| Q1 24 | — | 0.29× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AIP
| License And Maintenance | $17.5M | 87% |
| Variable Royalties And Other | $2.6M | 13% |
GYRE
Segment breakdown not available.
